Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/14/11/1640/478371/mdg456.pdf
Reference31 articles.
1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non-Small Cell Lung Cancer Collaborative Group;BMJ,1995
2. Evaluation of cisplatin intensity in metastatic non-small cell lung cancer: a phase III study of the Southwest Oncology Group;Gandara;J Clin Oncol,1993
3. Management strategies for recurrent non-small cell lung cancer;Fosella;Semin Oncol,1997
4. Paclitaxel by 1-hour infusion: an active drug in metastatic non-small cell lung cancer;Hainsworth;J Clin Oncol,1995
5. Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small cell lung cancer;Fosella;J Clin Oncol,1995
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study;Thoracic Cancer;2022-04-17
2. Interaction of Docetaxel with Phosphatidylcholine Membranes: A Combined Experimental and Computational Study;The Journal of Membrane Biology;2022-02-17
3. Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials;Translational Lung Cancer Research;2021-05
4. Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial;BMC Cancer;2018-07-31
5. Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer;Anti-Cancer Drugs;2017-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3